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Evaluation of an inspiratorymuscle trainer
in healthy humans (Respir Med 2001; 95: 526^
531): a replyWe thank Dr McConnell and her colleagues for their in-
terest in our paper.Our study was promptedby reportsin the lay media that the Powerbreatheswas of bene¢t
to athletes and patients with respiratory disease. A
search of the literature at the time that the study was
conceived yielded no peer-reviewed publications sup-
porting the use of the device.We deduce fromher letter
that Dr McConnell remains unable to cite such evidence
even now.
Accordingly, we performed a pilot study as detailed in
our paper.The results show that as judgedby PImax there
was a signi¢cant advantage to training which could not
be con¢rmed either by measurement of twitch trans-
diaphragmatic pressure or by other more sophisticated
volitional tests of inspiratorymuscle function, in particu-
lar themaximal sni¡ oesophageal pressure.On the basis
of this data, our conclusion was not that the device was
of no value butrather that a larger study waswarranted
to assess its e⁄cacy. In the interim, we argue that physi-
cians cannot recommend that either patients or health-
care providers purchase the device on the basis of
published data.
In addition,McConnelletal. suggest that twitch Pdi is a
£awed outcome measure with regard to inspiratory
muscle strength. The diaphragm is the most important
inspiratorymuscle in humans and itwouldbe hoped that
an e¡ective inspiratorymuscle trainer would result in in-
creased diaphragm strength. In any case, if the Power-
breathes did function by increasing, in isolation, the
strength of the extra diaphragmatic inspiratory muscles
we should have detected this using the sni¡ oesophageal
pressure measurement, which we did not. McConnell et
al. will also know that an alternative explanation for the
improvement in PImax seen in our study is recently pro-
videdbydata providedbyDemoule etal. (1).Their studies
showed that repeated inspiratorymuscle training over a
1week period produced a fall in the threshold required
to elicit a motor evoked potential recorded at the dia-
phragm by transcranial magnetic simulation of the dia-
phragm motor area suggesting that training may
in£uence the function of the brain as well as, potentially,
the function of themuscle.We suggest that this may re-
present an alternative explanation of the ¢nding that
PImax improves.
Finally, we would add that we provided data concern-
ing exercise and lung function because these are the out-
come measures that are likely to be most relevant to
patients.We accept that we did notmeasure all the out-
comemeasures suggested by McConnell et al., but, once
again, we should be most interested in seeing their data
produced in peer-reviewed form.When it does appear,
then the wider readership will have the opportunity of
comparing Dr McConnell’s own data with our own data,
which we believe is clearly presented in our paper (2). In
themeantime readersmay also be interested in the data
of Sonetti et al. (3), who showed that in competitive cy-
clists, compared with placebo, the Powerbreathes con-
ferred a slight increase in PImax (4.5%more thanplacebo).
LETTERSTOTHEEDITOR 133However, this also didnotresult in improvement in exer-
cise performance.
M.POLKEY
Department of Respiratory Medicine,
Royal Brompton Hospital, Sydney Street,
London,U.K.REFERENCES
1. Demoule A,Verin E, Derenne J-P, Similowski T. Plasticity of the hu-
man motor cortical representation of the diaphragm. Am J Respir
Crit Care Med 2001; 163: A46
2. Hart N, Sylvester K,Ward S,Cramer D, Moxham J, Polkey MI. Eva-
luation of an inspiratory muscle trainer in healthy humans. Respir
Med 2001; 95: 526^531.3. Sonetti DA, Wetter TJ, Pegelow DF,
Dempsey JA. E¡ects of respiratory muscle training versus placebo
on endurance exercise performance. Respir Physiol 2001; 127: 185^
199.
